# GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections

> **NCT06827990** · NA · RECRUITING · sponsor: **W.L.Gore & Associates** · enrollment: 112 (estimated)

## Conditions studied

- Aortic Dissection

## Interventions

- **DEVICE:** GORE® Ascending Stent Graft (ASG device)

## Key facts

- **NCT ID:** NCT06827990
- **Lead sponsor:** W.L.Gore & Associates
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-22
- **Primary completion:** 2030-09-01
- **Final completion:** 2031-09-01
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06827990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06827990, "GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06827990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
